
EMed Technologies
Internet, software, networking, and communications infrastructure products.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | Growth Equity non VC | |
Total Funding | 000k |
Related Content
eMed is a healthcare services organization specializing in population health management, with a focus on weight loss programs and chronic care for conditions like obesity and type 2 diabetes. The company primarily serves other organizations, offering its GLP-1 Weight Management Program as a health benefit for their employees. This B2B model is designed to help client organizations improve the health of their workforce while managing healthcare costs.
eMed utilizes its proprietary "Empathetic AI" to support its population health programs. In a significant expansion of its UK operations, eMed acquired the UK assets of Babylon Health in August 2023, continuing the delivery of healthcare services to former Babylon members.
Keywords: Population Health, Weight Management, Chronic Care, GLP-1, B2B Healthcare, Digital Health, AI Health, Obesity Treatment, Diabetes Management, Corporate Wellness
Tech stack
Investments by EMed Technologies
Edit
